Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement
10.1002/cncr.26311
Saved in:
Main Authors: | Kim, H.R., Shim, H.S., Chung, J.-H., Lee, Y.J., Hong, Y.K., Rha, S.Y., Kim, S.H., Ha, S.-J., Kim, S.K., Chung, K.Y., Soo, R., Kim, J.H., Cho, B.C. |
---|---|
Other Authors: | CANCER SCIENCE INSTITUTE OF SINGAPORE |
Format: | Article |
Published: |
2014
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/116983 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Lung Cancer in Never-Smokers
by: LIM WEI-YEN
Published: (2012) -
Reproductive factors and lung cancer risk: A comprehensive systematic review and meta-analysis
by: Yin, X., et al.
Published: (2021) -
RUNX3 downregulation in human lung adenocarcinoma is independent of p53, EGFR or KRAS status
by: Omar, M.F.M., et al.
Published: (2014) -
Personality differences between smokers and nonsmokers
by: Montemayor, Anthony Patrick G., et al.
Published: (1987) -
A subset of flavaglines inhibits KRAS nanoclustering and activation
by: Yurugi, Hajime, et al.
Published: (2021)